Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

A Mobile App (mHeart) to Detect Medication Nonadherence in the Heart Transplant Population: Validation Study.

Gomis-Pastor M, Roig E, Mirabet S, T De Pourcq J, Conejo I, Feliu A, Brossa V, Lopez L, Ferrero-Gregori A, Barata A, Mangues MA.

JMIR Mhealth Uhealth. 2020 Feb 4;8(2):e15957. doi: 10.2196/15957.

2.

Efficacy of therapeutic lifestyle changes on lipid profiles assessed by NMR in children with familial and non-familial hypercholesterolemia.

Rodríguez-Borjabad C, Malo AI, Ibarretxe D, Girona J, Heras M, Ferré R, Feliu A, Salvadó M, Varela A, Amigó N, Masana L, Plana N; DECOPIN Group; DECOPIN GROUP Investigators who have participated in patient recruitment.

Clin Investig Arterioscler. 2020 Jan 28. pii: S0214-9168(19)30120-2. doi: 10.1016/j.arteri.2019.10.001. [Epub ahead of print] English, Spanish.

PMID:
32005605
3.

2-arachidonoylglycerol reduces chondroitin sulphate proteoglycan production by astrocytes and enhances oligodendrocyte differentiation under inhibitory conditions.

Feliu A, Mestre L, Carrillo-Salinas FJ, Yong VW, Mecha M, Guaza C.

Glia. 2020 Jan 2. doi: 10.1002/glia.23775. [Epub ahead of print]

PMID:
31894889
4.

Patient perceptions of tobacco control after smoke-free hospital grounds legislation: Multi-center cross-sectional study.

Martínez C, Castellano Y, Fu M, Riccobene A, Feliu A, Tigova O, Ballbè M, Anton L, Fernández P, Cabrera-Jaime S, Puig-Llobet M, Moreno C, Falcó-Pegueroles A, Galimany J, Estrada JM, Guydish J, Fernández E; ETHIF Research Group.

Int J Nurs Stud. 2020 Feb;102:103485. doi: 10.1016/j.ijnurstu.2019.103485. Epub 2019 Nov 22.

PMID:
31862532
5.

Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis.

Mestre L, Carrillo-Salinas FJ, Mecha M, Feliú A, Espejo C, Álvarez-Cermeño JC, Villar LM, Guaza C.

Front Immunol. 2019 Jun 14;10:1374. doi: 10.3389/fimmu.2019.01374. eCollection 2019.

6.

Are smokers "hardening" or rather "softening"? An ecological and multilevel analysis across 28 European Union countries.

Feliu A, Fernandez E, Martinez C, Filippidis FT.

Eur Respir J. 2019 Sep 19;54(3). pii: 1900596. doi: 10.1183/13993003.00596-2019. Print 2019 Sep.

PMID:
31221812
7.

Impact of an Online Training Program in Smoking Cessation Interventions in Hospitals.

Martínez C, Castellano Y, Andrés A, Fu M, Feliu A, Antón L, Ballbè M, Fernández P, Cabrera S, Riccobene A, Gavilan E, Baena A, Margalef M, Tigova O, Quirós N, Guillen O, Company A, Fernández E.

J Nurs Scholarsh. 2019 Jul;51(4):449-458. doi: 10.1111/jnu.12469. Epub 2019 Mar 15.

PMID:
30874373
8.

The Obemat2.0 Study: A Clinical Trial of a Motivational Intervention for Childhood Obesity Treatment.

Luque V, Feliu A, Escribano J, Ferré N, Flores G, Monné R, Gutiérrez-Marín D, Guillen N, Muñoz-Hernando J, Zaragoza-Jordana M, Gispert-Llauradó M, Rubio-Torrents C, Núñez-Roig M, Alcázar M, Ferré R, Basora JM, Hsu P, Alegret-Basora C, Arasa F, Venables M, Singh P, Closa-Monasterolo R.

Nutrients. 2019 Feb 16;11(2). pii: E419. doi: 10.3390/nu11020419.

9.

Effectiveness of a telephone-based intervention for smoking cessation in patients with severe mental disorders: study protocol for a randomized controlled trial.

Ballbè M, Martínez C, Feliu A, Torres N, Nieva G, Pinet C, Raich A, Mondon S, Barrio P, Hernández-Ribas R, Vicens J, Costa S, Vilaplana J, Alaustre L, Vilalta E, Blanch R, Subirà S, Bruguera E, Suelves JM, Guydish J, Fernández E.

Trials. 2019 Jan 11;20(1):38. doi: 10.1186/s13063-018-3106-5.

10.

Prevalence and determinants of tobacco, e-cigarettes, and cannabis use among nursing students: A multicenter cross-sectional study.

Martínez C, Baena A, Castellano Y, Fu M, Margalef M, Tigova O, Feliu A, Laroussy K, Galimany J, Puig M, Bueno A, López A, Fernández E.

Nurse Educ Today. 2019 Mar;74:61-68. doi: 10.1016/j.nedt.2018.11.018. Epub 2018 Dec 7.

PMID:
30583124
11.

The endocannabinoid 2-AG enhances spontaneous remyelination by targeting microglia.

Mecha M, Yanguas-Casás N, Feliú A, Mestre L, Carrillo-Salinas F, Azcoitia I, Yong VW, Guaza C.

Brain Behav Immun. 2019 Mar;77:110-126. doi: 10.1016/j.bbi.2018.12.013. Epub 2018 Dec 21.

12.

Salivary immunity and lower respiratory tract infections in non-elite marathon runners.

Cantó E, Roca E, Perea L, Rodrigo-Troyano A, Suarez-Cuartin G, Giner J, Feliu A, Soria JM, Nescolarde L, Vidal S, Sibila O.

PLoS One. 2018 Nov 21;13(11):e0206059. doi: 10.1371/journal.pone.0206059. eCollection 2018.

13.

Detecting familial hypercholesterolemia earlier in life by actively searching for affected children:The DECOPIN project.

Ibarretxe D, Rodríguez-Borjabad C, Feliu A, Bilbao JÁ, Masana L, Plana N.

Atherosclerosis. 2018 Nov;278:210-216. doi: 10.1016/j.atherosclerosis.2018.09.039. Epub 2018 Oct 1.

PMID:
30312929
14.

Therapeutic potential of extracellular vesicles derived from human mesenchymal stem cells in a model of progressive multiple sclerosis.

Laso-García F, Ramos-Cejudo J, Carrillo-Salinas FJ, Otero-Ortega L, Feliú A, Gómez-de Frutos M, Mecha M, Díez-Tejedor E, Guaza C, Gutiérrez-Fernández M.

PLoS One. 2018 Sep 19;13(9):e0202590. doi: 10.1371/journal.pone.0202590. eCollection 2018.

15.

Exploring individual and contextual factors contributing to tobacco cessation intervention implementation.

Andrés A, Castellano Y, Fu M, Feliu A, Ballbè M, Antón L, Baena A, Fernández E, Martínez C.

Addict Behav. 2019 Jan;88:163-168. doi: 10.1016/j.addbeh.2018.08.003. Epub 2018 Aug 6.

PMID:
30205255
16.

Gut microbiota, cannabinoid system and neuroimmune interactions: New perspectives in multiple sclerosis.

Mestre L, Carrillo-Salinas FJ, Mecha M, Feliú A, Guaza C.

Biochem Pharmacol. 2018 Nov;157:51-66. doi: 10.1016/j.bcp.2018.08.037. Epub 2018 Aug 30. Review.

PMID:
30171835
17.

Smoking among hospitalized patients: A multi-hospital cross-sectional study of a widely neglected problem.

Martínez C, Fu M, Castellano Y, Riccobene A, Fernández P, Cabrera S, Gavilan E, Feliu A, Puig-Llobet M, Fuster P, Martínez-Sánchez JM, Montes J, Estrada JM, Moreno C, Falcó-Pegueroles A, Galimany J, Brando C, Suñer-Soler R, Capsada A, Fernández E; y Grupo de Coordinadores de la Red Catalana de Hospitales sin Humo (XCHsF).

Tob Induc Dis. 2018 Jul 30;16:34. doi: 10.18332/tid/92927. eCollection 2018.

18.

Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease Patients with Frequent Hospitalized Exacerbations: A Prospective Multicentre Study.

Rodrigo-Troyano A, Melo V, Marcos PJ, Laserna E, Peiro M, Suarez-Cuartin G, Perea L, Feliu A, Plaza V, Faverio P, Restrepo MI, Anzueto A, Sibila O.

Respiration. 2018;96(5):417-424. doi: 10.1159/000490190. Epub 2018 Jul 24.

19.

Impact of the Spanish smoking legislation among smokers: A longitudinal study with biomarkers in Barcelona (Spain).

Lidón-Moyano C, Fu M, Pérez-Ortuño R, Ballbè M, Feliu A, Martín-Sánchez JC, Matilla-Santander N, Pascual JA, Fernández E, Martínez-Sánchez JM.

Addict Behav. 2018 Dec;87:101-108. doi: 10.1016/j.addbeh.2018.06.023. Epub 2018 Jun 27.

PMID:
29975878
20.

Development of a Fluorescent Bodipy Probe for Visualization of the Serotonin 5-HT1A Receptor in Native Cells of the Immune System.

Hernández-Torres G, Enríquez-Palacios E, Mecha M, Feliú A, Rueda-Zubiaurre A, Angelina A, Martín-Cruz L, Martín-Fontecha M, Palomares O, Guaza C, Peña-Cabrera E, López-Rodríguez ML, Ortega-Gutiérrez S.

Bioconjug Chem. 2018 Jun 20;29(6):2021-2027. doi: 10.1021/acs.bioconjchem.8b00228. Epub 2018 May 14.

PMID:
29733594
21.

Lipid and lipoprotein parameters for detection of familial hypercholesterolemia in childhood. The DECOPIN Project.

Plana N, Rodríguez-Borjabad C, Ibarretxe D, Ferré R, Feliu A, Caselles A, Masana L; en representación del proyecto DECOPIN.

Clin Investig Arterioscler. 2018 Jul - Aug;30(4):170-178. doi: 10.1016/j.arteri.2017.12.003. Epub 2018 Mar 27. English, Spanish.

PMID:
29602595
22.

Characterization of the population with severe iron deficiency anemia at risk of requiring intravenous iron supplementation.

Estadella J, Villamarín L, Feliu A, Perelló J, Calaf J.

Eur J Obstet Gynecol Reprod Biol. 2018 May;224:41-44. doi: 10.1016/j.ejogrb.2018.03.005. Epub 2018 Mar 6.

PMID:
29529476
23.

Identification of Pseudomonas aeruginosa and airway bacterial colonization by an electronic nose in bronchiectasis.

Suarez-Cuartin G, Giner J, Merino JL, Rodrigo-Troyano A, Feliu A, Perea L, Sanchez-Reus F, Castillo D, Plaza V, Chalmers JD, Sibila O.

Respir Med. 2018 Mar;136:111-117. doi: 10.1016/j.rmed.2018.02.008. Epub 2018 Feb 13.

PMID:
29501241
24.

Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy.

Navarrete C, Carrillo-Salinas F, Palomares B, Mecha M, Jiménez-Jiménez C, Mestre L, Feliú A, Bellido ML, Fiebich BL, Appendino G, Calzado MA, Guaza C, Muñoz E.

J Neuroinflammation. 2018 Mar 1;15(1):64. doi: 10.1186/s12974-018-1103-y.

25.

2-AG limits Theiler's virus induced acute neuroinflammation by modulating microglia and promoting MDSCs.

Mecha M, Feliú A, Machín I, Cordero C, Carrillo-Salinas F, Mestre L, Hernández-Torres G, Ortega-Gutiérrez S, López-Rodríguez ML, de Castro F, Clemente D, Guaza C.

Glia. 2018 Jul;66(7):1447-1463. doi: 10.1002/glia.23317. Epub 2018 Feb 27.

PMID:
29484707
26.

Impact of tobacco control policies on smoking prevalence and quit ratios in 27 European Union countries from 2006 to 2014.

Feliu A, Filippidis FT, Joossens L, Fong GT, Vardavas CI, Baena A, Castellano Y, Martínez C, Fernández E.

Tob Control. 2019 Jan;28(1):101-109. doi: 10.1136/tobaccocontrol-2017-054119. Epub 2018 Feb 22.

27.

Lipoprotein profile assessed by 2D-1H-NMR and subclinical atherosclerosis in children with familial hypercholesterolaemia.

Rodríguez-Borjabad C, Ibarretxe D, Girona J, Ferré R, Feliu A, Amigó N, Guijarro E, Masana L, Plana N; DECOPIN Group.

Atherosclerosis. 2018 Mar;270:117-122. doi: 10.1016/j.atherosclerosis.2018.01.040. Epub 2018 Jan 31.

PMID:
29407879
28.

Factors associated with implementation of the 5A's smoking cessation model.

Martínez C, Castellano Y, Andrés A, Fu M, Antón L, Ballbè M, Fernández P, Cabrera S, Riccobene A, Gavilan E, Feliu A, Baena A, Margalef M, Fernández E.

Tob Induc Dis. 2017 Nov 2;15:41. doi: 10.1186/s12971-017-0146-7. eCollection 2017.

29.

Plasma inducible degrader of the LDLR, soluble low-density lipoprotein receptor, and proprotein convertase subtilisin/kexin type 9 levels as potential biomarkers of familial hypercholesterolemia in children.

Girona J, Rodríguez-Borjabad C, Ibarretxe D, Heras M, Amigo N, Feliu A, Masana L, Plana N; DECOPIN Group.

J Clin Lipidol. 2018 Jan - Feb;12(1):211-218. doi: 10.1016/j.jacl.2017.10.003. Epub 2017 Oct 12.

PMID:
29102496
30.

2-Arachidonoylglycerol Reduces Proteoglycans and Enhances Remyelination in a Progressive Model of Demyelination.

Feliú A, Bonilla Del Río I, Carrillo-Salinas FJ, Hernández-Torres G, Mestre L, Puente N, Ortega-Gutiérrez S, López-Rodríguez ML, Grandes P, Mecha M, Guaza C.

J Neurosci. 2017 Aug 30;37(35):8385-8398. doi: 10.1523/JNEUROSCI.2900-16.2017. Epub 2017 Jul 27.

31.

Gut dysbiosis and neuroimmune responses to brain infection with Theiler's murine encephalomyelitis virus.

Carrillo-Salinas FJ, Mestre L, Mecha M, Feliú A, Del Campo R, Villarrubia N, Espejo C, Montalbán X, Álvarez-Cermeño JC, Villar LM, Guaza C.

Sci Rep. 2017 Mar 14;7:44377. doi: 10.1038/srep44377.

32.

Prevalence and clinical impact of recreational drug consumption in people living with HIV on treatment: a cross-sectional study.

Garin N, Zurita B, Velasco C, Feliu A, Gutierrez M, Masip M, Mangues MA.

BMJ Open. 2017 Jan 18;7(1):e014105. doi: 10.1136/bmjopen-2016-014105.

33.

Correction: Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55.

Lopez de Lapuente A, Feliú A, Ugidos N, Mecha M, Mena J, Astobiza I, Riera J, Carrillo-Salinas FJ, Comabella M, Montalban X, Alloza I, Guaza C, Vandenbroeck K.

J Immunol. 2016 Nov 15;197(10):4177. No abstract available.

34.

Erratum to: Initial Approach to Childhood Obesity in Spain. A Multisociety Expert Panel Assessment.

Vilallonga R, Moreno Villares JM, Yeste Fernández D, Sánchez Santos R, Casanueva Freijo F, Santolaya Ochando F, Leal Hernando N, Lecube Torelló A, Castaño González LA, Feliu A, Lopez-Nava G, Frutos D, de la Cruz Vigo F, Torres Garcia AJ, de Ruiz de Adana JC.

Obes Surg. 2017 Apr;27(4):1007. doi: 10.1007/s11695-016-2451-2. No abstract available.

PMID:
27807765
35.

Initial Approach to Childhood Obesity in Spain. A Multisociety Expert Panel Assessment.

Vilallonga R, Moreno Villares JM, Yeste Fernández D, Sánchez Santos R, Casanueva Freijo F, Santolaya Ochando F, Leal Hernando N, Lecube Torelló A, Castaño González LA, Feliu A, Lopez-Nava G, Frutos D, de la Cruz Vigo F, Torres Garcia AJ, Ruiz de Adana JC.

Obes Surg. 2017 Apr;27(4):997-1006. doi: 10.1007/s11695-016-2413-8. Erratum in: Obes Surg. 2017 Apr;27(4):1007.

PMID:
27752806
36.

Letter to the editor regarding the paper by A. Lozano-Blázquez et al. Differences in cancer drug assessment between Spain and the United Kingdom.

Prat A, Gilabert A, Puig-Peiro R, Feliu A, Riba M, Mangues MA, Tabernero J.

Eur J Cancer. 2016 Nov;67:55-56. doi: 10.1016/j.ejca.2016.07.023. Epub 2016 Sep 4. No abstract available.

PMID:
27599024
37.

Microglia activation states and cannabinoid system: Therapeutic implications.

Mecha M, Carrillo-Salinas FJ, Feliú A, Mestre L, Guaza C.

Pharmacol Ther. 2016 Oct;166:40-55. doi: 10.1016/j.pharmthera.2016.06.011. Epub 2016 Jun 29. Review.

PMID:
27373505
38.

Multifocal Lymphangioendotheliomatosis with Thrombocytopenia: Presentation of Two Cases Treated with Sirolimus.

Lanöel A, Torres Huamani AN, Feliú A, Sala MJ, Alvarez M, Cervini AB.

Pediatr Dermatol. 2016 Jul;33(4):e235-9. doi: 10.1111/pde.12879. Epub 2016 Jun 10.

PMID:
27282436
39.

Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55.

Lopez de Lapuente A, Feliú A, Ugidos N, Mecha M, Mena J, Astobiza I, Riera J, Carrillo-Salinas FJ, Comabella M, Montalban X, Alloza I, Guaza C, Vandenbroeck K.

J Immunol. 2016 Jun 1;196(11):4553-65. doi: 10.4049/jimmunol.1501205. Epub 2016 May 4. Erratum in: J Immunol. 2016 Nov 15;197(10 ):4177.

40.

Prevalence of allergic sensitization to conifer pollen in a high cypress exposure area.

Domínguez-Ortega J, López-Matas MÁ, Alonso MD, Feliú A, Ruiz-Hornillos J, González E, Moya R, Carnés J.

Allergy Rhinol (Providence). 2016 Jan 1;7(4):200-206. doi: 10.2500/ar.2016.7.0183.

41.

Skewed X Inactivation in Women Carrying the FMR1 Premutation and Its Relation with Fragile-X-Associated Tremor/Ataxia Syndrome.

Alvarez-Mora MI, Rodriguez-Revenga L, Feliu A, Badenas C, Madrigal I, Milà M.

Neurodegener Dis. 2016;16(3-4):290-2. doi: 10.1159/000441566. Epub 2015 Nov 27.

PMID:
26609701
42.

The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9-tetrahydrocannabinol acting through CB1 receptors.

Moreno-Martet M, Feliú A, Espejo-Porras F, Mecha M, Carrillo-Salinas FJ, Fernández-Ruiz J, Guaza C, de Lago E.

Mult Scler Relat Disord. 2015 Nov;4(6):505-11. doi: 10.1016/j.msard.2015.08.001. Epub 2015 Aug 5.

PMID:
26590655
43.

Corrigendum: Recreational drug use among individuals living with HIV in Europe: review of the prevalence, comparison with the general population and HIV guidelines recommendations.

Garin N, Velasco C, De Pourcq JT, Lopez B, Gutierrez Mdel M, Haro JM, Feliu A, Mangues MA, Trilla A.

Front Microbiol. 2015 Nov 3;6:1229. doi: 10.3389/fmicb.2015.01229. eCollection 2015. No abstract available.

44.

Recreational drug use among individuals living with HIV in Europe: review of the prevalence, comparison with the general population and HIV guidelines recommendations.

Garin N, Velasco C, De Pourcq JT, Lopez B, Gutierrez Mdel M, Haro JM, Feliu A, Mangues MA, Trilla A.

Front Microbiol. 2015 Jul 14;6:690. doi: 10.3389/fmicb.2015.00690. eCollection 2015.

45.

Endocannabinoids drive the acquisition of an alternative phenotype in microglia.

Mecha M, Feliú A, Carrillo-Salinas FJ, Rueda-Zubiaurre A, Ortega-Gutiérrez S, de Sola RG, Guaza C.

Brain Behav Immun. 2015 Oct;49:233-45. doi: 10.1016/j.bbi.2015.06.002. Epub 2015 Jun 15.

PMID:
26086345
46.

A Sativex(®) -like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis.

Feliú A, Moreno-Martet M, Mecha M, Carrillo-Salinas FJ, de Lago E, Fernández-Ruiz J, Guaza C.

Br J Pharmacol. 2015 Jul;172(14):3579-95. doi: 10.1111/bph.13159. Epub 2015 May 20.

47.

[Obesity associated metabolic impairment is evident at early ages: Spanish collaborative study].

Martos-Moreno GÁ, Gil-Campos M, Bueno G, Bahillo P, Bernal S, Feliu A, Lechuga-Sancho AM, Palomo E, Ruiz R, Vela A; Grupo de Trabajo de Obesidad de la Sociedad Española de Endocrinología Pediátrica (SEEP).

Nutr Hosp. 2014 Oct 1;30(4):787-93. doi: 10.3305/nh.2014.30.4.7661. Spanish.

48.

A reversible and selective inhibitor of monoacylglycerol lipase ameliorates multiple sclerosis.

Hernández-Torres G, Cipriano M, Hedén E, Björklund E, Canales Á, Zian D, Feliú A, Mecha M, Guaza C, Fowler CJ, Ortega-Gutiérrez S, López-Rodríguez ML.

Angew Chem Int Ed Engl. 2014 Dec 8;53(50):13765-70. doi: 10.1002/anie.201407807. Epub 2014 Oct 8.

PMID:
25298214
49.

A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis.

Carrillo-Salinas FJ, Navarrete C, Mecha M, Feliú A, Collado JA, Cantarero I, Bellido ML, Muñoz E, Guaza C.

PLoS One. 2014 Apr 11;9(4):e94733. doi: 10.1371/journal.pone.0094733. eCollection 2014.

50.

Brain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid system.

Hernangómez M, Carrillo-Salinas FJ, Mecha M, Correa F, Mestre L, Loría F, Feliú A, Docagne F, Guaza C.

Curr Pharm Des. 2014;20(29):4707-22. Review.

Supplemental Content

Support Center